Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,532 results for ""Ifosfamide""

Your Filters

Subject : sarcoma
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience.

  • Authors : Ishiyama Y; Department of Urology, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.; Department of Urology and Transplant Surgery, Toda Chuo General Hospital, Saitama, Japan.

Subjects: Ifosfamide*/Ifosfamide*/Ifosfamide*/administration & dosage ; Ifosfamide*/Ifosfamide*/Ifosfamide*/adverse effects ; Doxorubicin*/Doxorubicin*/Doxorubicin*/administration & dosage

  • Source: Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 3213-3220.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Doxorubicin Combined With Ifosfamide for Sarcoma Induces Muscle Atrophy and Sleep Disruption.

  • Authors : Kinoshita H; Department of Orthopedic Surgery, Chiba Cancer Center, Chiba, Japan; .

Subjects: Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/*adverse effects ; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*adverse effects ; Doxorubicin/Doxorubicin/Doxorubicin/*adverse effects

  • Source: Anticancer research [Anticancer Res] 2021 Dec; Vol. 41 (12), pp. 6273-6278.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis.

  • Authors : Hua Q; Cancer center, Union hospital, Tongji medical college, Huazhong university of science and technology, Wuhan, China.; Xu G

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use VACA protocol

  • Source: Journal of chemotherapy (Florence, Italy) [J Chemother] 2021 Sep; Vol. 33 (5), pp. 319-327. Date of Electronic Publication: 2021 Jan 27.Publisher: Taylor & Francis Country of Publication: England NLM ID: 8907348 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA".

  • Authors : Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of Oncology, KU Leuven, Laboratory of Experimental Oncology, Leuven, Belgium. Electronic address: .

Subjects: Medical Futility*; Ifosfamide/Ifosfamide/Ifosfamide/*administration & dosage ; Indoles/Indoles/Indoles/*administration & dosage

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jul; Vol. 152, pp. 26-40. Date of Electronic Publication: 2021 May 29.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

  • Authors : Schmoll HJ; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin Luther University, Halle-Wittenberg, Germany.; Lindner LH

Subjects: Ifosfamide*/Ifosfamide*/Ifosfamide*/adverse effects ; Sarcoma*/Sarcoma*/Sarcoma*/drug therapy; Adult

  • Source: JAMA oncology [JAMA Oncol] 2021 Feb 01; Vol. 7 (2), pp. 255-262.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: a single-institution retrospective analysis.

  • Authors : Saito S; Department of Orthopedic Surgery, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.; Aiba H

Subjects: Doxorubicin/Doxorubicin/Doxorubicin/*analogs & derivatives ; Etoposide/Etoposide/Etoposide/*administration & dosage ; Ifosfamide/Ifosfamide/Ifosfamide/*administration & dosage

  • Source: BMC cancer [BMC Cancer] 2020 Sep 09; Vol. 20 (1), pp. 868. Date of Electronic Publication: 2020 Sep 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Doxorubicin/Doxorubicin/Doxorubicin/*administration & dosage

  • Source: American journal of clinical oncology [Am J Clin Oncol] 2020 Jun; Vol. 43 (6), pp. 446-451.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma.

  • Authors : Vornicova O; Cancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, 1834111, Afula, Israel.; Haim N

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/administration & dosage ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacokinetics

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 Oct; Vol. 84 (4), pp. 919-923. Date of Electronic Publication: 2019 Aug 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model.

  • Authors : Higuchi T; AntiCancer, Inc., San Diego, CA, USA; Department of Surgery, University of California, San Diego, CA, USA

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacology ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: Cancer letters [Cancer Lett] 2019 Jun 01; Vol. 451, pp. 122-127. Date of Electronic Publication: 2019 Mar 10.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Ifosfamide/Ifosfamide/Ifosfamide/*therapeutic use ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*therapeutic use

  • Source: Investigational new drugs [Invest New Drugs] 2018 Jun; Vol. 36 (3), pp. 468-475. Date of Electronic Publication: 2018 Mar 12.Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  4,532 results for ""Ifosfamide""